Non-Comedogenic Effect of UV Doux Glowy Fluid Sunscreen

A Clinical Study to Evaluate the Non-Comedogenic Effect of UV Doux Glowy Fluid Sunscreen - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/07/114104

Enrollment

Registered

2026-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test product: UV Doux Glowy Fluid Sunscreen: Dose: Gently use the product once a day for 4 weeks. Route of Administration: Topical, Duration: 28 Days Control Intervention1: Not Applicab

Eligibility

Inclusion criteria

Inclusion criteria: 1. Gender: Male or Female with age 18-45 2. Subject Having oily or mixed oily skin with comedones on the face. 3. Subjects willing to give written informed consent 4. Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 5. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 6. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation natural or artificial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years or any other confounding skin condition. 3. Have any condition that in the opinion of the investigator, would confound the safety and efficacy assessments of the product. 4. Have participated in any interventional clinical trial in the previous 30 days. 5. Have a known sensitivity to any of the constituents of the test product including sensitivities to the test product ingredients 6. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication such as biologics including corticosteroids. 7.Having applied a cosmetic product included make-up on the studied areas the first day of the study only face cleaned with water is accepted. 8. Having applied hair oil during the entire duration of the study. 9. No Chronic illness.

Design outcomes

Primary

Measure	Time frame
1.Change in Comedone Count, Open and close comedones 2. Change in inflammatory lesionsTimepoint: At T0, T+14 Days telephonic visit, T+28 Days	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results